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A B S T R A C T
This paper is concerned with large-gauge needle biopsies of suspicious breast neopla-
sia performed within a three-year period (22nd June 1999 through 21st December 2001).
Within that time 262 large-gauge needle biopsies as well as cytological punctions were
performed with the aim of diagnosing benign and malignant neoplasia. In the same
three-year period 29 malignant breast tumors were diagnosed. In one of the patients a
clinically and PHD verified alteration was found which pointed to Mb. Padget, while in
another patient an atypical ductal hyperplasia was confirmed by a pathohistological
test.
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Introduction
Breast cancer holds the first position
among malignant neoplasia as a cause of
death in women. This statement is true
for the Republic of Croatia as well as for
most countries in the world1,2. Over the
last thirty years or so there has been a
constant increase in the occurrence of
breast cancer and in the death rate due to
this illness. Thus in 1970 there were 681
newly established cases of breast cancer
in women (rate 14.3 per 100,000) and in
the same year 327 women died of breast
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cancer (rate 14.3 per 100,000). Ten years
later, in 1980, there were 1,127 newly es-
tablished cases of breast cancer (rate 47.5
per 100,000), and in the same year 456
women died from the same cause (19.1/
100,000). Indications of a constant in-
crease were recorded ten years later, so in
1990 there were 1,461 newly diagnosed
patients with breast cancer (59.3/100,000),
and in the same year 710 women died of
it (29.9/100,000). The latest evidence con-
cerning the occurrence of breast cancer
according to the Cancer Register of the
Republic of Croatia shows that in 1995
the number was that far the highest ever:
1,779 cases (72.2/100,000) and that in the
same year 768 women died of that cause
(31.2/ 100,000). The latest evidence bear-
ing on the death rate due to breast cancer
in women dates from 1998 when, accord-
ing to the Cancer Register for the Repub-
lic of Croatia, 794 women died of that ill-
ness (32.2/100,000)1,2.
Based on the afore-mentioned data
concerning the increase of occurrence of
breast cancer and the death rate of breast
cancer patients it becomes obvious that
between 1970 and 1996 the incidence of
the illness increased by 242% and the
death rate by 218%1,2.
Compared to other countries of the
world the Republic of Croatia shows a
medium incidence of breast cancer, and
within its boundaries the front position is
held by Istria, Primorsko-Goranska coun-
ty and Zagreb. The highest incidence of
breast cancer in the world has been re-
corded in the developed countries of North
America and Europe, whereas the lowest
incidence has been found in some Asian
and African countries1,2.
In 5% of newly diagnosed patients with
breast cancer in the Republic of Croatia
the tumor has spread regionally, whereas
in 26% it shows distant metastases. This
fact affects the possibilities, the results
and the success of treatment as well as
the future prospects which are much
poorer if patients with breast cancer have
started treatment at an advanced stage
of illness i.e. after the tumor has spread
(which is the most common case)1–5.
The risk of breast cancer occurrence
grows with age and is greater for women
with personal and family history includ-
ing breast cancer cases. The following
factors are also indications of a higher
risk of breast cancer occurrence: early
menarche, late menopause, prolonged ap-
plication of oral contraceptives, prolong-
ed use of estrogen in the postmenopausal
period, nulliparity, first childbirth after
30 years of age, higher educational level,
higher socioeconomic status and atypical
breast hyperplasia confirmed by biopsy.
Among the factors suspected to affect
breast cancer but still lacking scientific
confirmation are the following: ethnical
differences influencing differences in diet
(specifically fat intake), the influence of
pesticides, alcohol consumption, obesity,
induced breech of pregnancy and physical
inactivity2,4–12. Large-gauge needle biopsy
of malignant breast neoplasia has nowa-
days proved to be a choice method, partic-
ularly if it is ultrasound- guided and not
random13–18.
Materials and Methods
This paper deals with large-gauge nee-
dle biopsies of suspicious breast neopla-
sia performed in the Division for Breast
Diseases of the Department for Gynecol-
ogy and Obstetrics of the General Hospi-
tal »Zabok»in Zabok within a three-year
period (22nd June 1999 through 21st De-
cember 2001). Within that time 262 large
-gauge needle biopsies as well as cytologi-
cal punctions were performed with the
aim of diagnosing benign and malignant
breast neoplasia. Thirty large-gauge nee-
dle biopsies of breast neoplasia found sus-
picious in previous ultrasound and mam-
mographic tests were carried out. Large
-gauge needle biopsies were ultrasound
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-guided which resulted in a high level of
accuracy of the diagnostic test. A precon-
dition for executing large-gauge needle
biopsies in case of suspicious neoplasm
was a previous mam- mographic test and
a detailed ultrasound breast examination
enabling us to locate suspicious growths
with a high level of precision and to in-
crease the accuracy of the subsequent bi-
opsy. For the purpose of carrying out large
-gauge needle biopsies of potentially ma-
lignant breast neoplasia an automatic
»pistol« BARD-MAGNUM with thick nee-
dles (18–14 Gauge diameter which equals
1.7–2.1 mm) was applied. We averagely
used 4 cylinders of tissue obtained by
large-gauge needle biopsy, which was la-
ter processed in the Department for Pa-
thology of our hospital, and this proce-
dure has resulted in a very accurate pa-
thohistological diagnosis.
Results and Discussion
In the afore-mentioned three-year pe-
riod 29 patients with a malignant breast
neoplasia were diagnosed (by exact PHD
verification of samples obtained through
large-gauge needle biopsy). In one patient
a clinically confirmed alteration pointed to
Mb. Padget. The age evaluation of exa-
minees falls within the 95% reliability in-
terval, which in this case amounts to 46.8
to 52.4 years of age. Their span extends
from 31 to a maximum of 82 years of age
with a standard deviation of 9.63 years.
The number of childbirths ranges from 0
to 9 with a standard deviation of 1.96.
There were 47.22% of women with 2 child-
births and 34.24% of women with only
one childbirth. The pathohistological find-
ings of 29 patients pointed to a ductal in-
vasive breast cancer. In one patient Mb.
Padget was confirmed and in another pa-
tient an atypical ductal hyperplasia was
found. It was proved that for the whole
group of 30 patients with a suspicious ul-
trasound or mammographic finding point-
ing to malignant breast neoplasia, the
pathohistological diagnosis correlated in
96.66%, while only in one patient an aty-
pical ductal hyperplasia was verified
(3.33%). The average size of tumors was
18 mm. In analyzing the interrelation-
ship of pathohistological findings in sam-
ples obtained by large-gauge needle bi-
opsy and the diagnostic methods pointing
to suspicious malignant breast neoplasia
there is low probability that these two
methods could be independent, because of
p<0.1 which points to the acceptability of
the hypothesis about a high correlation
between an accurate mammographic and
ultrasound diagnosis and its pathohisto-
logical verification.
Conclusion
The results that have been obtained
prove the acceptability of ultrasound-
guided large-gauge needle biopsy in de-
tecting malignant breast neoplasia. We
have shown that by means of the above-
described method very reliable results
have been obtained as well as a rather ac-
curate pathological verification of malig-
nant breast neoplasia without causing se-
rious trauma to the patients. The ad-
vantage of teamwork between the gyne-
cologist, the radiologist, the pathologist,
the cytologist and the surgeon should be
emphasized as particularly important be-
cause it guarantees good results in treat-
ing patients affected by malignant breast
neoplasia. In our hospital such a team is
in charge of the whole diagnostic and
therapeutic procedure including the sur-
gery.
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[IROKOIGLENA BIOPSIJA U DIJAGNOSTICI ZLO]UDNIH
NOVOTVORINA DOJKE
S A @ E T A K
U ovom radu izvr{ili smo prikaz u~injenih {irokoiglenih biopsija u suspektnih novo-
tvorina dojke u trogodi{njem razdoblju (od 22.06.1999. do 31.12.2001. godine). U tom
vremenu u~inili smo 262 {irokoiglene biopsija te citolo{kih punkcija u dijagnostici do-
bro}udnih i zlo}udnih novotvorina dojki. U navedenom trogodi{njem razdoblju dijag-
nosticirali smo u 29 bolesnika zlo}udnu novotvorinu dojki. U jedne bolesnice radilo se o
klini~ki i PHD-om verificiranoj promjeni koja je govorila za Mb. Padget, dok se u jedne
bolesnice patohistolo{kim nalazom verificiralo atipi~nu duktalnu hiperplaziju.
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